{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:53Z","timestamp":1792791593922,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031580","name":"National Vaccine Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031580","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Southeast Asia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lansea.2026.100857","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:33:11Z","timestamp":1788874391000},"page":"100857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effectiveness of a trivalent inactivated split-virion influenza vaccine (Tri Fluvac) in Thailand: a phase IV test-negative case-control study"],"prefix":"10.1016","volume":"53","author":[{"given":"Wachiraporn","family":"Arunothong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1602-5435","authenticated-orcid":false,"given":"Thundon","family":"Ngamprasertchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janjira","family":"Thaipadungpanit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Napat","family":"Phetkub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amornkarn","family":"Thongbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanokwan","family":"Saengsawang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ponthip","family":"Wirachwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isariya","family":"Techatanawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somchaiya","family":"Surichan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piengthong","family":"Narakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritchawat","family":"Boonya-anan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amnat","family":"Khamsiriwatchara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaranit","family":"Kaewkungwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4841-7924","authenticated-orcid":false,"given":"Saranath","family":"Lawpoolsri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lansea.2026.100857_bib1","series-title":"Immunization VaBI","first-page":"79","article-title":"Evaluation of influenza vaccine effectiveness - a guide to the design and interpretation of observational studies","year":"2017"},{"key":"10.1016\/j.lansea.2026.100857_bib2","author":"Program WHE"},{"issue":"2","key":"10.1016\/j.lansea.2026.100857_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-017271","article-title":"Seasonal influenza surveillance and vaccination policies in the WHO South-East Asian Region","volume":"10","author":"Haider","year":"2025","journal-title":"BMJ Glob Health"},{"issue":"Suppl 1","key":"10.1016\/j.lansea.2026.100857_bib5","doi-asserted-by":"crossref","first-page":"A29","DOI":"10.1016\/j.vaccine.2011.04.120","article-title":"Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: addressing the threat of an influenza pandemic","volume":"29","author":"Surichan","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.lansea.2026.100857_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.vaccine.2023.11.050","article-title":"Safety and immunogenicity of locally produced trivalent inactivated influenza vaccine (Tri Fluvac) in healthy Thai adults aged 18-64 years in Nakhon Phanom: a phase III double blinded, three-arm, randomized, controlled trial","volume":"42","author":"Prasert","year":"2024","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.lansea.2026.100857_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12874-025-02611-4","article-title":"Over- and under-estimation of vaccine effectiveness","volume":"25","author":"De-Leon","year":"2025","journal-title":"BMC Med Res Methodol"},{"issue":"25","key":"10.1016\/j.lansea.2026.100857_bib9","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2017.04.037","article-title":"Case-control vaccine effectiveness studies: preparation, design, and enrollment of cases and controls","volume":"35","author":"Verani","year":"2017","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.lansea.2026.100857_bib10","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1016\/j.vaccine.2017.07.003","article-title":"Basic principles of test-negative design in evaluating influenza vaccine effectiveness","volume":"35","author":"Fukushima","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.lansea.2026.100857_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijid.2021.03.045","article-title":"The \"timeless\" use of influenza-like illness criteria for influenza detection in the tropics","volume":"106","author":"Aung","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"67","key":"10.1016\/j.lansea.2026.100857_bib12","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.21105\/joss.03773","article-title":"Nextclade: clade assignment, mutation calling and quality control for viral genomes","volume":"6","author":"Aksamentov","year":"2021","journal-title":"J Open Source Softw"},{"issue":"13","key":"10.1016\/j.lansea.2026.100857_bib13","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494","article-title":"GISAID: global initiative on sharing all influenza data - from vision to reality","volume":"22","author":"Shu","year":"2017","journal-title":"Euro Surveill"},{"issue":"8","key":"10.1016\/j.lansea.2026.100857_bib14","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1017\/S095026881500309X","article-title":"Regression approaches in the test-negative study design for assessment of influenza vaccine effectiveness","volume":"144","author":"Bond","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"12","key":"10.1016\/j.lansea.2026.100857_bib15","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1017\/S0950268816000832","article-title":"Adjusting for calendar time in a TND influenza study","volume":"144","author":"Nauta","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"11","key":"10.1016\/j.lansea.2026.100857_bib16","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1093\/aje\/kwaa084","article-title":"Temporal confounding in the test-negative design","volume":"189","author":"Dean","year":"2020","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.lansea.2026.100857_bib17","series-title":"Evaluation of COVID-19 Vaccine Effectiveness","year":"2021"},{"issue":"9","key":"10.1016\/j.lansea.2026.100857_bib19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s40265-024-02083-8","article-title":"Influenza vaccine effectiveness and progress towards a universal influenza vaccine","volume":"84","author":"Cowling","year":"2024","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.lansea.2026.100857_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.15585\/mmwr.mm7406a2","article-title":"Interim estimates of 2024-2025 seasonal influenza vaccine effectiveness - four vaccine effectiveness networks, United States, October 2024-February 2025","volume":"74","author":"Frutos","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.lansea.2026.100857_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/irv.70115","article-title":"Interim estimates of 2024-2025 seasonal influenza vaccine effectiveness in Germany-data from primary care and hospital sentinel surveillance","volume":"19","author":"Erdwiens","year":"2025","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.lansea.2026.100857_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107202","article-title":"Influenza epidemiology and vaccine effectiveness during the 2023\/2024 season in Italy: a test-negative case-control study","volume":"147","author":"Domnich","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"33","key":"10.1016\/j.lansea.2026.100857_bib23","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1016\/j.vaccine.2023.06.072","article-title":"Influenza vaccine effectiveness in preventing hospital encounters for laboratory-confirmed infection among Italian adults, 2022\/23 season","volume":"41","author":"Domnich","year":"2023","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.lansea.2026.100857_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/irv.70023","article-title":"Influenza vaccine effectiveness against symptomatic influenza in primary care: a test negative case control study over two influenza seasons 2022\/2023 and 2023\/2024 in Ireland","volume":"18","author":"Marron","year":"2024","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.lansea.2026.100857_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2024.100517","article-title":"Influenza virus circulation and vaccine effectiveness during June 2021-May 2023 in Thailand","volume":"19","author":"Prasert","year":"2024","journal-title":"Vaccine X"},{"issue":"1","key":"10.1016\/j.lansea.2026.100857_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2435156","article-title":"Influenza vaccine effectiveness against medically-attended influenza infection in 2023\/24 season in Hangzhou, China","volume":"21","author":"Lei","year":"2025","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.lansea.2026.100857_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf560","article-title":"Effectiveness of the 2023 southern hemisphere influenza vaccine against outpatient influenza-like illness: a multi-country test-negative design study","volume":"12","author":"Regan","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.lansea.2026.100857_bib28","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/S2214-109X(24)00473-X","article-title":"Effectiveness of 2023 southern hemisphere influenza vaccines against severe influenza-associated illness: pooled estimates from eight countries using the test-negative design","volume":"13","author":"Gharpure","year":"2025","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.lansea.2026.100857_bib29","doi-asserted-by":"crossref","first-page":"861","DOI":"10.15585\/mmwr.mm7339a1","article-title":"Interim effectiveness estimates of 2024 southern hemisphere influenza vaccines in preventing influenza-associated hospitalization \u2014 REVELAC-i network, five South American Countries, March\u2013July 2024","volume":"73","author":"Zeno","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.lansea.2026.100857_bib30","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/14760584.2025.2596673","article-title":"High-dose influenza vaccine: enhanced protection for the elderly","volume":"24","author":"Trombetta","year":"2025","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.lansea.2026.100857_bib31","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1080\/21645515.2020.1747375","article-title":"Immunogenicity of influenza vaccine in elderly people: a systematic review and meta-analysis of randomized controlled trials, and its association with real-world effectiveness","volume":"16","author":"Meng","year":"2020","journal-title":"Hum Vaccin Immunother"}],"container-title":["The Lancet Regional Health - Southeast Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368226001423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368226001423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:00:51Z","timestamp":1792789251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772368226001423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":28,"alternative-id":["S2772368226001423"],"URL":"https:\/\/doi.org\/10.1016\/j.lansea.2026.100857","relation":{},"ISSN":["2772-3682"],"issn-type":[{"value":"2772-3682","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of a trivalent inactivated split-virion influenza vaccine (Tri Fluvac) in Thailand: a phase IV test-negative case-control study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Southeast Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lansea.2026.100857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100857"}}